We evaluated and analysed our own 31 cases of the haemorrhagic type of
moyamoya disease to clarify the clinical features of this disease. Th
e cases were divided into three groups. Group A consisted of 12 cases
with aneurysms. Aneurysms on the circle of Willis were treated as ordi
nary saccular aneurysms. Group B consisted of 14 cases with intracereb
ral haemorrhage (ICH) without aneurysms. These were managed almost as
spontaneous ICH. Group C consisted of 5 cases with intraventricular ha
emorrhage (IVH) without aneurysm or ICH. Twenty-two surgical procedure
s for aneurysms. ICH and IVH were done in 19 cases (62%). Nine teen pr
ocedures for preventing future strokes were undertaken in 11 cases (35
%). The overall initial outcome was excellent in 12 cases (39%). good
in 7 cases (23%). pool in 7 cases (23%). and death in 5 cases (15%). D
uring the follow-up period (mean: 6.5 years. rebleeding occurred in tw
o cases (8%), and ischaemic attacks in two cases (8%). The rate of reb
leeding or ischaemic attacks was 1.19% per patient-year during the fol
low-up period. There was no ischaemic or rebleeding episode in cases t
reated by STA-MCA bypass with encephalomyosynagiosis (EMS) during the
follow-up period. Management of the primary haemorrhage should be acco
rding to the clinical condition, type of haemorrhage. and sourer of ha
emorrhage. When the patient needs to undergo revascularization surgery
to prevent future strokes, we recommend STA-MCA bypass with EMS inste
ad of encephaloduro-arteriosynangiosis (EDAS).